Archives tagged: pricing spineometer

NIKE Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD December 31, 2025

NIKE, an athletic footwear, apparel, and equipment company selling NIKE, Jordan, and Converse brands, had a negative FY 2025. Revenue fell 9.8%…

More

Allegion Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD December 5, 2025

Allegion, a global provider of branded security products, had a positive FY 2024. Revenue rose 3.3% to $3.8 billion and earnings before…

More

Quest Diagnostics Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Quest Diagnostics, a U.S. healthcare diagnostic company, had a positive FY 2024. Revenue rose 6.7% to $9.87 billion, and earnings before interest…

More

Edwards Lifesciences Corporation Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Edwards Lifesciences, a global leader in structural heart innovation, reported a positive FY 2024. Revenue rose 8.6% to $5.4 billion and earnings…

More

LabCorp Holdings Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

LabCorp, a laboratory services company for medical providers, pharmaceuticals, and researchers, had a positive FY 2024. Revenue rose 7% to $13.0 billion,…

More

Moderna Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD November 7, 2025

Moderna, a leader in mRNA medicine best known for its COVID vaccine, had a mixed FY 2024. Revenue fell 53% to $3.2…

More

Where and When is the Inflationary Impact of Tariffs?

By Tim J. Smith, PhD October 1, 2025

Tariffs are in the news, but will they have no to little impact on inflation? What can we expect in the next…

More

Bristol-Myers Squibb Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Bristol-Myers Squibb, a global biopharmaceutical company, had a mixed FY 2024. Revenue rose 7.3% to $48.3 billion while operating earnings fell 199%…

More

Regeneron Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Regeneron, a biotechnology company, had a mixed FY 2024. Revenue rose 8.3% to $14.2 billion, while operating profit fell 3.6% to $4.0…

More

Baxter Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD October 1, 2025

Baxter, a global healthcare product company, had a mixed FY 2024. Revenue rose 2.7% to $10.6 billion, while operating income fell 98%…

More